Literature DB >> 15991130

Blood management: issues and options.

John J Callaghan1, Michael R O'Rourke, Steve S Liu.   

Abstract

Blood management in the perioperative period of the total joint arthroplasty procedure has evolved over the last 3 decades. Strategies have changed and are changing based on a better understanding of blood loss and blood replacement options in this patient population. Patient-specific options based on preoperative hemoglobin levels and patient comorbidities as well as anticipated blood loss have been developed and studied. Patient-specific blood management programs have provided cost-efficient care with low morbidity.

Entities:  

Mesh:

Year:  2005        PMID: 15991130     DOI: 10.1016/j.arth.2005.03.018

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  24 in total

1.  Does tranexamic acid save blood in minimally invasive total knee arthroplasty?

Authors:  Po-Chun Lin; Chi-Hsiang Hsu; Wun-Schen Chen; Jun-Wen Wang
Journal:  Clin Orthop Relat Res       Date:  2011-02-01       Impact factor: 4.176

Review 2.  Practical issues for the use of tranexamic acid in total knee arthroplasty: a systematic review.

Authors:  Tae Kyun Kim; Chong Bum Chang; In Jun Koh
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-03-31       Impact factor: 4.342

3.  Reduced blood loss and operation time in lumbar posterolateral fusion using a bipolar sealer.

Authors:  Daisuke Fukui; Mamoru Kawakami; Shin-Ichi Nakao; Erabu Miyamoto; Shouko Morishita; Toshiko Matuoka; Hiroshi Yamada
Journal:  Eur Spine J       Date:  2016-06-08       Impact factor: 3.134

4.  Tranexamic acid reduces allogenic transfusion in revision hip arthroplasty.

Authors:  Shahryar Noordin; Terrence S Waters; Donald S Garbuz; Clive P Duncan; Bassam A Masri
Journal:  Clin Orthop Relat Res       Date:  2011-02       Impact factor: 4.176

5.  No Difference in Blood Loss and Risk of Transfusion Between Patients Treated with One or Two Doses of Intravenous Tranexamic Acid After Simultaneous Bilateral TKA.

Authors:  Jeffrey M Wilde; Steven N Copp; Kace A Ezzet; Adam S Rosen; Richard H Walker; Julie C McCauley; Audree S Evans; William D Bugbee
Journal:  Clin Orthop Relat Res       Date:  2022-04-01       Impact factor: 4.176

6.  Preoperative erythropoietin alpha reduces postoperative transfusions in THA and TKA but may not be cost-effective.

Authors:  Hany Bedair; Judy Yang; Maureen K Dwyer; Joseph C McCarthy
Journal:  Clin Orthop Relat Res       Date:  2015-02       Impact factor: 4.176

7.  Operative Time Directly Correlates with Blood Loss and Need for Blood Transfusion in Total Joint Arthroplasty.

Authors:  David Ross; Omer Erkocak; Mohammad R Rasouli; Javad Parvizi
Journal:  Arch Bone Jt Surg       Date:  2019-05

8.  Intra-articular injection of tranexamic acid via a drain plus drain-clamping to reduce blood loss in cementless total knee arthroplasty.

Authors:  Hirotaka Mutsuzaki; Kotaro Ikeda
Journal:  J Orthop Surg Res       Date:  2012-09-29       Impact factor: 2.359

9.  The Use of Epoetin-α in Revision Knee Arthroplasty.

Authors:  Lawrence A Delasotta; Ashwin V Rangavajjula; Michael L Frank; Jamie L Blair; Fabio R Orozco; Alvin C Ong
Journal:  Adv Orthop       Date:  2012-07-01

10.  Should We Use Preoperative Epoetin-α in the Mildly Anemic Patient Undergoing Simultaneous Total Knee Arthroplasty?

Authors:  Lawrence A Delasotta; Fabio Orozco; S Mehdi Jafari; Jamie L Blair; Alvin Ong
Journal:  Open Orthop J       Date:  2013-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.